RSV Maternal Unadjuvanted Vaccine

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRSV Maternal Unadjuvanted Vaccine
Drug Alias NameRSV MAT
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Uk Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Uk Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A